Business Description
VentriPoint Diagnostics Ltd
NAICS : 621510
SIC : 8633
ISIN : CA92281P2008
Description
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -8.72 | |||||
Debt-to-Equity | -0.63 | |||||
Debt-to-EBITDA | -0.98 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -209.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.8 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 30.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.28 | |||||
9-Day RSI | 45.35 | |||||
14-Day RSI | 44.23 | |||||
3-1 Month Momentum % | 26.21 | |||||
6-1 Month Momentum % | -4.41 | |||||
12-1 Month Momentum % | -19.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.08 | |||||
Quick Ratio | 0.08 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 44.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | -6.07 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1899.44 | |||||
Net Margin % | -1788.27 | |||||
EBITDA Margin % | -1489.94 | |||||
FCF Margin % | -874.11 | |||||
OCF Margin % | -874.11 | |||||
ROA % | -548.12 | |||||
ROIC % | -155.19 | |||||
3-Year ROIIC % | 65.35 | |||||
ROC (Joel Greenblatt) % | -1780.03 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 102.5 | |||||
EV-to-EBIT | -7.99 | |||||
EV-to-EBITDA | -8.17 | |||||
EV-to-Revenue | 121.74 | |||||
EV-to-FCF | -14.01 | |||||
Earnings Yield (Greenblatt) % | -12.52 | |||||
FCF Yield % | -8.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VentriPoint Diagnostics Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.112 | ||
| EPS (TTM) (€) | -0.012 | ||
| Beta | 2.6793 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.48 | ||
| Volatility % | 60.83 | ||
| 14-Day RSI | 44.23 | ||
| 14-Day ATR (€) | 0.003191 | ||
| 20-Day SMA (€) | 0.058425 | ||
| 12-1 Month Momentum % | -19.75 | ||
| 52-Week Range (€) | 0.039 - 0.094 | ||
| Shares Outstanding (Mil) | 187.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VentriPoint Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VentriPoint Diagnostics Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
VentriPoint Diagnostics Ltd Frequently Asked Questions
What is VentriPoint Diagnostics Ltd(FRA:5V7)'s stock price today?
The current price of FRA:5V7 is €0.06. The 52 week high of FRA:5V7 is €0.09 and 52 week low is €0.04.
When is next earnings date of VentriPoint Diagnostics Ltd(FRA:5V7)?
The next earnings date of VentriPoint Diagnostics Ltd(FRA:5V7) is .
Does VentriPoint Diagnostics Ltd(FRA:5V7) pay dividends? If so, how much?
VentriPoint Diagnostics Ltd(FRA:5V7) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on VentriPoint Diagnostics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers